Toggle navigation
Home
Search
Services
Blog
Contact
About
Apoptosis Inhibitors - Therapy for Neurotoxicity
Pulliam, Lynn
Neurex Corporation, Menlo Park, CA, United States
Search 44 grants from Lynn Pulliam
Search grants from Neurex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Defining the Mechanism of Delayed Xenograft Rejection
Defining the Mechanism of Delayed Xenograft Rejection
Delay of Gratification - Substance Use/Abuse/Dependence
Protonation of O and S in Metalloproteins and Models
Recently added grants:
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping
The Pathogenic Role of Interneurons in Huntington's Disease
Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seq
Eph-ephrin signaling in the lens
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH056311-01
Application #
2256468
Study Section
Small Business Research Review Committee (MHSB)
Project Start
1996-08-01
Project End
1997-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Neurex Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Publications
Pulliam, L; Zhou, M; Stubblebine, M et al.
(1998)
Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor.
J Neurosci Res 54:530-8
Comments
Be the first to comment on Lynn Pulliam's grant